Showing results (51-60 of 154) with videos related to
Sort By:
Pageof 16
Chemical Communications (Cambridge, England)|November 23, 2019
A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8Francesca Nardelli, Michela Ghitti, Giacomo Quilici, et al.Advanced Drug Delivery Reviews|October 11, 2011
How to improve exposure of tumor cells to drugs: promoter drugs increase tumor uptake and penetration of effector drugsFabrizio Marcucci, Angelo CortiDrug Discovery Today|June 19, 2012
Improving drug penetration to curb tumor drug resistanceFabrizio Marcucci, Angelo CortiAnnals of the New York Academy of Sciences|January 15, 2005
Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugsAngelo Corti, Mirco PonzoniJournal of Experimental & Clinical Cancer Research : CR|March 7, 2025
Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growthAnna Maria Gasparri, Arianna Pocaterra, Barbara Colombo, et al.Advanced Functional Materials|October 6, 2017
Glycine N-methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate formation and Integrin Binding without Impairing CD13 Recognition and Tumor HomingAngelo Corti, Anna Maria Gasparri, Michela Ghitti, et al.Annals of the New York Academy of Sciences|October 8, 2019
Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulationSushil K Mahata, Angelo CortiCellular and Molecular Life Sciences : CMLS|October 10, 2014
Chromogranin A: a paradoxical player in angiogenesis and vascular biologyKaren B Helle, Angelo CortiOncotarget|September 30, 2016
Regulation of tumor growth by circulating full-length chromogranin AFlavio Curnis, Alice Dallatomasina, Mimma Bianco, et al.Frontiers in Oncology|January 11, 2021
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal AdenocarcinomaMichele Reni, Valentina Andreasi, Anna Maria Gasparri, et al.Pageof 16